Skip to content

Clinical trials

Completed Phase 1 Memory Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Phase: Phase 1 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20103
20131
20141
20171
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Prof. Dr. Dieter Willbold2
Ionis Pharmaceuticals, Inc.1
Life Extension Foundation Inc.1
Memorial Sloan Kettering Cancer Center1
National Institute on Aging (NIA)1
Posit Science Corporation1
Vanderbilt University1
Wake Forest University Health Sciences1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders12
Alzheimer Disease5
Cognitive Dysfunction4
Amnesia1
Astrocytoma1
Brain Neoplasms1
Breast Neoplasms1
Chemotherapy-Related Cognitive Impairment1
Dementia1
Glioblastoma1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.